Arrowhead Research Corporation announced has announced that that the U.S. Food and Drug Administration has approved the Investigational New Drug ("IND") application submitted by its majority-owned ...
Building effective IT 101: Forget what you’ve heard about aligning IT to the business. In the digital era, IT-business integration is the true key to organizational success. IT, CIOs are frequently ...
Insert Therapeutics, Inc. has that it has filed with the U.S. Food and Drug Administration to initiate a Phase II clinical trial evaluating the safety and efficacy of its drug candidate, IT-101 in ...